Jorge Barriuso
@drjorgebarriuso.bsky.social
Consultant (clinician-scientist) in medical oncology with an interest in Lower GI malignancies including appendix tumours and peritoneal metastasis. #H12O #imas12 #rarecancers #translationalresearch #drugdevelopment
Another outstanding discussion from Dra. Elena Élez on WSI H&Es AI used to predict response on the italian ATEZOTRIBE / AVATRIC cohorts and STELLAR-303.
👉 What about microbiome and tertiary lymphoid structures (TLS)
👉More translational studies needed
#ESMO25 @myesmo.bsky.social
👉 What about microbiome and tertiary lymphoid structures (TLS)
👉More translational studies needed
#ESMO25 @myesmo.bsky.social
October 20, 2025 at 8:14 AM
Another outstanding discussion from Dra. Elena Élez on WSI H&Es AI used to predict response on the italian ATEZOTRIBE / AVATRIC cohorts and STELLAR-303.
👉 What about microbiome and tertiary lymphoid structures (TLS)
👉More translational studies needed
#ESMO25 @myesmo.bsky.social
👉 What about microbiome and tertiary lymphoid structures (TLS)
👉More translational studies needed
#ESMO25 @myesmo.bsky.social
An amazing discussion by Dr Sharlene Gill on the updates of CHECKMATE 8HW and BREAKWATER.
👉 Can we identify patients deriving benefit from single agent IO in MMRd /MSI-H metastatic CRC?
👉Is there any room to rechallenge in BRAF mCRC?
#ESMODailyReporter @myesmo.bsky.social
👉 Can we identify patients deriving benefit from single agent IO in MMRd /MSI-H metastatic CRC?
👉Is there any room to rechallenge in BRAF mCRC?
#ESMODailyReporter @myesmo.bsky.social
October 20, 2025 at 7:58 AM
An amazing discussion by Dr Sharlene Gill on the updates of CHECKMATE 8HW and BREAKWATER.
👉 Can we identify patients deriving benefit from single agent IO in MMRd /MSI-H metastatic CRC?
👉Is there any room to rechallenge in BRAF mCRC?
#ESMODailyReporter @myesmo.bsky.social
👉 Can we identify patients deriving benefit from single agent IO in MMRd /MSI-H metastatic CRC?
👉Is there any room to rechallenge in BRAF mCRC?
#ESMODailyReporter @myesmo.bsky.social
Deeply honoured for participating in #ESSO44 Gothenburg as speaker in the session Progress in Pseudomyxoma Peritonei Therapy! @essonews.bsky.social
To Berlin now for an exciting #ESMO25 @myesmo.bsky.social #ESMODailyReporter
and shortly see you at PSOGI meeting in Barcelona
To Berlin now for an exciting #ESMO25 @myesmo.bsky.social #ESMODailyReporter
and shortly see you at PSOGI meeting in Barcelona
October 16, 2025 at 1:43 PM
Deeply honoured for participating in #ESSO44 Gothenburg as speaker in the session Progress in Pseudomyxoma Peritonei Therapy! @essonews.bsky.social
To Berlin now for an exciting #ESMO25 @myesmo.bsky.social #ESMODailyReporter
and shortly see you at PSOGI meeting in Barcelona
To Berlin now for an exciting #ESMO25 @myesmo.bsky.social #ESMODailyReporter
and shortly see you at PSOGI meeting in Barcelona
Thank you @myesmo.bsky.social #ESMOGI2025 chairs & organizing committee to bring GI #rarecancers to the stage and having me in good company. I hope I brought some awareness to #appendixcancers #pseudomyxoma #peritonealmesothelioma
#ESMOAmbassadors
@acpmpresearch.bsky.social
#ESMOAmbassadors
@acpmpresearch.bsky.social
July 6, 2025 at 9:16 AM
Thank you @myesmo.bsky.social #ESMOGI2025 chairs & organizing committee to bring GI #rarecancers to the stage and having me in good company. I hope I brought some awareness to #appendixcancers #pseudomyxoma #peritonealmesothelioma
#ESMOAmbassadors
@acpmpresearch.bsky.social
#ESMOAmbassadors
@acpmpresearch.bsky.social
Interesting mini-Oral presentation from Dr Francesca Negri about the assessment of tumour immune microenvironment as a prognostic marker in Locally Advanced Rectal Cancer using a cohort from STAR-01 #ESMOGI25 @myesmo.bsky.social #ESMOAmbassadors
July 5, 2025 at 7:51 AM
Interesting mini-Oral presentation from Dr Francesca Negri about the assessment of tumour immune microenvironment as a prognostic marker in Locally Advanced Rectal Cancer using a cohort from STAR-01 #ESMOGI25 @myesmo.bsky.social #ESMOAmbassadors
Impressive review of the use of blood based assays for screening in Colorectal Cancer at #ESMOGI25 by Prof Sinicrope
Take a closer look at the takeaway points!! @myesmo.bsky.social #ESMOAmbassadors
Take a closer look at the takeaway points!! @myesmo.bsky.social #ESMOAmbassadors
July 4, 2025 at 8:40 AM
Impressive review of the use of blood based assays for screening in Colorectal Cancer at #ESMOGI25 by Prof Sinicrope
Take a closer look at the takeaway points!! @myesmo.bsky.social #ESMOAmbassadors
Take a closer look at the takeaway points!! @myesmo.bsky.social #ESMOAmbassadors
AI revolution coming to #ESMOGI25 Very interesting presentations from Prof Magali Svrcek and @jnkt.bsky.social about the use and potential of #ArtificialIntelligence @myesmo.bsky.social #ESMOAmbassadors
July 3, 2025 at 10:09 AM
AI revolution coming to #ESMOGI25 Very interesting presentations from Prof Magali Svrcek and @jnkt.bsky.social about the use and potential of #ArtificialIntelligence @myesmo.bsky.social #ESMOAmbassadors
Amazing trip through translational research in colorectal cancer from Sanger sequencing to Single Cell by Prof. Federica de Nicolantonio at @myesmo.bsky.social #ESMOGI25 #ESMOAmbassadors
July 3, 2025 at 8:43 AM
Amazing trip through translational research in colorectal cancer from Sanger sequencing to Single Cell by Prof. Federica de Nicolantonio at @myesmo.bsky.social #ESMOGI25 #ESMOAmbassadors
Starting the 2nd day at @myesmo.bsky.social #ESMOGI25 with a Multidisciplinary Tumour Board in Rectal Cancer! #ESMOAmbassadors
July 3, 2025 at 7:11 AM
Starting the 2nd day at @myesmo.bsky.social #ESMOGI25 with a Multidisciplinary Tumour Board in Rectal Cancer! #ESMOAmbassadors